A tuberculosis biomarker database: the key to novel TB diagnostics

Area of Science:

• Biomedical diagnostics
• Infectious disease research
• Bioinformatics

Background:

• Effective tuberculosis (TB) diagnostics are crucial for achieving End TB Strategy goals.
• Despite extensive research and investment, a simple, rapid, and accurate TB diagnostic test remains unavailable.
• The identification of novel, non-DNA biomarkers is a key research priority.

Purpose of the Study:

• To address the 'biomarker pipeline problem' by creating a centralized TB biomarker database.
• To facilitate the dynamic tracking of biomarker evidence against target product profiles (TPPs).
• To accelerate the development and clinical translation of new TB diagnostic tools.

Main Methods:

• Development of a web-based, user-friendly TB biomarker database.
• Inclusion of functionality to accommodate raw datasets for verification.
• Enabling the identification of novel biomarker combinations.

Main Results:

• The database will simplify data and knowledge sharing among researchers and stakeholders.
• It will empower collaboration and aid in coordinating research efforts and resource allocation.
• The platform will streamline the verification and validation processes for biomarker candidates.

Conclusions:

• The TB biomarker database is expected to significantly accelerate the translation of research into clinically useful diagnostic tools.
• Improved data sharing and verification processes will enhance the efficiency of biomarker discovery.
• This initiative is vital for overcoming current limitations in TB diagnostics and meeting global health targets.